Back to Results
First PageMeta Content
Matter / Science / Lithium / Lithium pharmacology / Treatment of bipolar disorder / Drug discovery / Design of experiments / Clinical trial / Pharmaceutical drug / Chemistry / Pharmacology / Mood stabilizers


HD Phase I Clinical Trial of NP03 [Aonys - lithium] successfully completedIn the email I just sent on Lithuim, I referenced a NPO3 Phase I clinical trial [Aonys - lithium] for HD would start in 2010 in Fran
Add to Reading List

Document Date: 2011-07-25 18:53:25

Open Document

File Size: 29,50 KB

Share Result on Facebook

Company

Medesis Pharma / /

Continent

North America / Europe / /

Country

France / /

Event

Analyst Recommendation / FDA Phase / /

IndustryTerm

treatment of Huntington’s disease / pharmaceutical product / drug delivery technology / treatment of bipolar disorder / metal ions / /

MedicalCondition

bipolar disorders / multiple sclerosis / diseases / disease / chronic long term treatment / neurodegenerative diseases / Huntington’s disease / bipolar disorder / /

Organization

Committee for Orphan Medicinal Products / /

Person

Jean-Claude Maurel / /

Position

representative / President and CEO / /

Product

Lithium citrate / HD / NP03 / /

Technology

drug delivery technology / /

URL

www.medesispharma.com / http /

SocialTag